Cargando…

Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones

BACKGROUND: Thiazolidinedione is a pentacyclic moiety having five membered unsaturated ring system composed with carbon, oxygen, nitrogen and sulfur molecules at 1 and 3 position of the thiazole ring and widely found throughout nature in various form. They favourably alter concentration of the hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sucheta, Tahlan, Sumit, Verma, Prabhakar Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768028/
https://www.ncbi.nlm.nih.gov/pubmed/30515635
http://dx.doi.org/10.1186/s13065-018-0496-0
_version_ 1783455042008776704
author Sucheta
Tahlan, Sumit
Verma, Prabhakar Kumar
author_facet Sucheta
Tahlan, Sumit
Verma, Prabhakar Kumar
author_sort Sucheta
collection PubMed
description BACKGROUND: Thiazolidinedione is a pentacyclic moiety having five membered unsaturated ring system composed with carbon, oxygen, nitrogen and sulfur molecules at 1 and 3 position of the thiazole ring and widely found throughout nature in various form. They favourably alter concentration of the hormones secreted by adipocytes, particularly adiponectin. They also increase total body fat and have mixed effects on circulating lipids. Thiazolidinedione nucleus is present in numerous biological moieties and has different pharmacological activities likes, e.g. antimalarial, antimicrobial, antimycobacterial, anticonvulsant, antiviral, anticancer, anti-inflammatory, antioxidant, anti-HIV (human immunodeficiency virus) and antituberculosis. RESULTS AND DISCUSSION: The synthesized compounds were screened for their in vitro antimicrobial potential against Gram (positive and negative) bacterial and fungal strains by tube dilution technique. In this series, compound 10 exhibited significant antimicrobial activity against B. subtilis and S. aureus with MIC = 4.2 × 10(−2) µM/ml, compound 15 showed significant activity against K. pneumonia with MIC = 2.60 × 10(−2) µM/ml and compound 4 displayed potent antibacterial activity against E. coli with MIC = 4.5 × 10(−2) µM/ml. Compound 10 had most potent antifungal activity against C. albicans and A. niger with MIC = 4.2 × 10(−2) µM/ml. Compounds 12 and 15 were found as most active antidiabetic agents having IC(50) = 27.63 μg/ml and 22.35 μg/ml, respectively, using DPPH assay. Antioxidant activity results indicated that compounds 3 and 9 displayed good antioxidant agent with IC(50) = 29.04 μg/ml and 27.66 μg/ml respectively, using α amylase assay. CONCLUSION: All the synthesized derivatives exhibited good antimicrobial, antidiabetic and antioxidant activities using specific methods then compared with mentioned standard drugs. Especially, compounds 3, 4, 9, 10, 12 and 15 displayed highest activity. Structure activity relationship demonstrated that presence of electron withdrawing group (o-NO(2), p-Cl, p-Br) enhanced the antibacterial activity against E. coli as well as increased the antioxidant activity while the presence of electron releasing group (o/p-OCH(3), 3,4,5-trimethoxy) enhanced the antibacterial activity against S. aureus, B. subtilis, S. typhi, K. pneumonia, C. albicans and A. niger as well as the antidiabetic activity.
format Online
Article
Text
id pubmed-6768028
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-67680282019-10-03 Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones Sucheta Tahlan, Sumit Verma, Prabhakar Kumar Chem Cent J Research Article BACKGROUND: Thiazolidinedione is a pentacyclic moiety having five membered unsaturated ring system composed with carbon, oxygen, nitrogen and sulfur molecules at 1 and 3 position of the thiazole ring and widely found throughout nature in various form. They favourably alter concentration of the hormones secreted by adipocytes, particularly adiponectin. They also increase total body fat and have mixed effects on circulating lipids. Thiazolidinedione nucleus is present in numerous biological moieties and has different pharmacological activities likes, e.g. antimalarial, antimicrobial, antimycobacterial, anticonvulsant, antiviral, anticancer, anti-inflammatory, antioxidant, anti-HIV (human immunodeficiency virus) and antituberculosis. RESULTS AND DISCUSSION: The synthesized compounds were screened for their in vitro antimicrobial potential against Gram (positive and negative) bacterial and fungal strains by tube dilution technique. In this series, compound 10 exhibited significant antimicrobial activity against B. subtilis and S. aureus with MIC = 4.2 × 10(−2) µM/ml, compound 15 showed significant activity against K. pneumonia with MIC = 2.60 × 10(−2) µM/ml and compound 4 displayed potent antibacterial activity against E. coli with MIC = 4.5 × 10(−2) µM/ml. Compound 10 had most potent antifungal activity against C. albicans and A. niger with MIC = 4.2 × 10(−2) µM/ml. Compounds 12 and 15 were found as most active antidiabetic agents having IC(50) = 27.63 μg/ml and 22.35 μg/ml, respectively, using DPPH assay. Antioxidant activity results indicated that compounds 3 and 9 displayed good antioxidant agent with IC(50) = 29.04 μg/ml and 27.66 μg/ml respectively, using α amylase assay. CONCLUSION: All the synthesized derivatives exhibited good antimicrobial, antidiabetic and antioxidant activities using specific methods then compared with mentioned standard drugs. Especially, compounds 3, 4, 9, 10, 12 and 15 displayed highest activity. Structure activity relationship demonstrated that presence of electron withdrawing group (o-NO(2), p-Cl, p-Br) enhanced the antibacterial activity against E. coli as well as increased the antioxidant activity while the presence of electron releasing group (o/p-OCH(3), 3,4,5-trimethoxy) enhanced the antibacterial activity against S. aureus, B. subtilis, S. typhi, K. pneumonia, C. albicans and A. niger as well as the antidiabetic activity. Springer International Publishing 2018-12-04 /pmc/articles/PMC6768028/ /pubmed/30515635 http://dx.doi.org/10.1186/s13065-018-0496-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sucheta
Tahlan, Sumit
Verma, Prabhakar Kumar
Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title_full Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title_fullStr Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title_full_unstemmed Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title_short Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones
title_sort synthesis, sar and in vitro therapeutic potentials of thiazolidine-2,4-diones
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768028/
https://www.ncbi.nlm.nih.gov/pubmed/30515635
http://dx.doi.org/10.1186/s13065-018-0496-0
work_keys_str_mv AT sucheta synthesissarandinvitrotherapeuticpotentialsofthiazolidine24diones
AT tahlansumit synthesissarandinvitrotherapeuticpotentialsofthiazolidine24diones
AT vermaprabhakarkumar synthesissarandinvitrotherapeuticpotentialsofthiazolidine24diones